Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. [electronic resource] by
- Shernan, Stanton K
- Fitch, Jane C K
- Nussmeier, Nancy A
- Chen, John C
- Rollins, Scott A
- Mojcik, Christopher F
- Malloy, Kevin J
- Todaro, Thomas G
- Filloon, Thomas
- Boyce, Steven W
- Gangahar, Deepak M
- Goldberg, Michael
- Saidman, Lawrence J
- Mangano, Dennis T
Producer: 20040408
In:
The Annals of thoracic surgery vol. 77
Availability: No items available.
|